Multiple sclerosis

Autoimmunity

Volumn 37, Issue 4, 2004, Pages 321-324

  Berger, Thomas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; MYELIN BASIC PROTEIN; PROTEIN ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CEREBROSPINAL FLUID LEVEL; DEMYELINATION; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROGNOSIS; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

AUTOANTIBODIES; BIOLOGICAL MARKERS; HUMANS; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 4444263314     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930410001708742     Document Type: Article

References (36)

1. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G. (2000) "Mult. Scler.", New Engl. J. Med. 343, 938-952.
2. Hemmer, B., Archelos, J.J. and Hartung, H.P. (2002) "New concepts in the immunopathogenesis of multiple sclerosis", Nat. Neurosci. Rev. 3, 291-301.
3. Lucchinetti, C., Brück, W., Parisi, J., Scheithauer, B., Rodriguez, M. and Lassmann, H. (2000) "Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination", Ann. Neurol. 47, 707-717.
4. Lassmann, H., Brück, W. and Lucchinetti, C. (2001) "Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy", Trends Mol. Med. 7, 115-121.
5. Kornek, B. and Lassmann, H. (2003) "Neuropathology of multiple sclerosis - new concepts", Brain Res. Bull. 61, 321-326.
6. Storch, M.K., Piddlesden, S., Haltia, M., Ivanainen, M., Morgan, P. and Lassmann, H. (1998) "Multiple sclerosis: in situ evidence for antibody- and complement mediated demyelination", Ann. Neurol. 43, 465-471.
7. Lassmann, H., Reindl, M., Rauschka, H., Berger, J., Aboul-Enein, F., Berger, T., Zurbriggen, A., Lutterotti, A., Brück, W., Weber, J.R., Ullrich, R., Schmidbauer, M., Jellinger, K. and Vandervelde, M. (2003) "A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions", Brain 126, 1-11.
8. Kabat, E.A., Glusman, M. and Knaub, V. (1948) "Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods", Am. J. Med. 4, 653-662.
9. Bornstein, M.B. and Appel, S.H. (1961) "The application of tissue culture to the study of experimental allergic encephalomyelitis. 1. Patterns of demyelination", J. Neuropathol. Exp. Neurol. 20, 141-147.
10. Archelos, J.J., Storch, M.K. and Hartung, H.P. (2000) "The role of B cells and antibodies in multiple sclerosis", Ann. Neurol. 47, 694-706.
11. Cross, A.H., Trotter, J.L. and Lyons, J.A. (2001) "B cells and antibodies in CNS demyelinating disease", J. Neuroimmunol. 112, 1-14.
12. Reindl, M., Linington, C., Brehm, U., Egg, R., Dilitz, E., Deisenhammer, F., Poewe, W. and Berger, T. (1999) "Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological disease: a comparative study", Brain 122, 2047-2056.
13. Egg, R., Reindl, M., Deisenhammer, F., Linington, C. and Berger, T. (2001) "Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis", Mult. Scler. 7, 285-289.
14. Brück, W., Neubert, K., Berger, T. and Weber, J.R. (2001) "Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination - possible markers for an antibody-mediated process", Mult. Scler 7, 173-177.
15. Zeman, A.Z.J., Kidd, D., McLean, B.N., Kelly, M.A., Francis, D.A., Miller, D.H., Kendall, B.E., Rudge, P., Thompson, E.J. and McDonald, W.I. (1996) "A study of oligoclonal band negative multiple sclerosis", J. Neurol. Neurosurg. Psych. 60, 27-30.
16. Villar, L.M., Masjuan, J., Gonzalez-Porque, P., Plaza, J., Sadaba, M.C., Roldan, E., Bootello, A. and Alvarez-Cermeno, J.C. (2003) "Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis", Ann. Neurol. 53, 222-226.
17. Villar, L.M., Masjuan, J., Gonzalez-Porque, P., et al. (2002) "Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS", Neurology 59, 555-559.
18. Olsson, J.E. and Link, H. (1973) "Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remission", Arch. Neurol. 28, 392-399.
19. Silber, E., Semra, Y.K., Gregson, N.A. and Sharief, M.K. (2002) "Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit", Neurology 58, 1372-1381.
20. Galboiz, Y. and Miller, A. (2002) "Immunological indicators of disease activity and prognosis in multiple sclerosis", Curr. Opin. Neurol. 15, 233-237.
21. Berger, T., Rubner, P., Egg, R., Schautzer, F., Ulmer, H., Mayringer, I., et al. (2003) "Antimyelin antibodies as predictors for clinical definite multiple sclerosis in patients with a first demyelinating event", New Engl. J. Med. 146, 181-197.
22. Cruz, M., Olsson, T., Ernerudh, J., Hojeberg, B. and Link, H. (1987) "Immunoblot detection of oligoclonal antimyelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis" , Neurology 37, 1515-1519.
23. Warren, K.G. and Catz, I. (1994) "Relative frequency of autoantibodies to myelin basic protein and proteolipidprotein in optic neuritis and multiple sclerosis cerebrospinal fluid", J. Neurol. Sci. 121, 66-73.
24. Sun, J.B., Olsson, T., Wang, W.Z., Xiao, B.G., Fredrikson, S., Ekre, H.P. and Link, H. (1991) "Autoreactive T and B cells responding to myelin proeolipid protein in multiple sclerosis and controls", Eur. J. Immunol. 21, 1461-1468.
25. Xiao, B.G., Linington, C. and Link, H. (1991) "Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls", J. Neuroimmunol. 31, 91-96.
26. Genain, C.P., Cannella, B., Hauser, S.L. and Raine, C.S. (1999) "Identification of autoantibodies associated with myelin damage in multiple sclerosis", Nat. Med. 5, 170-175.
27. Moller, J.R., Johnson, D., Brady, R.O., Tourtelotte, W.W. and Quarles, R.H. (1989) "Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients", J. Neuroimmunol. 22, 55-61.
28. Bronstein, J.M., Lallone, R.L., Seitz, R.S., Ellison, G.W. and Myers, L.W. (1999) "A humoral response to oligodendrocyte-specific protein in MS: a potntial molecular mimic" , Neurology 53, 154-161.
29. Walsh, M.J. and Murray, J.M. (1998) "Dual implication of 2′,3′-cyclic nucleotide 3 phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis", J. Clin. Investig. 101, 1923-1931.
30. Banki, K., Colombo, E., Sia, F., Halladay, D., Mattson, D.H., Tatum, A.H., Massa, P.T., Phillipps, P.E. and Perl, A. (1994) "Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis", J. Exp. Med. 180, 1649-1663.
31. Achiron, N., Rio, J., Fernandez, A.L., Tintore, M., Duran, I., Galan, I. and Montalban, X. (1996) "Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis", Acta Neurol. Scand. 93, 99-103.
32. Archelos, J.J., Trotter, J., Previtali, S., Weissbrich, B., Toyka, K.V. and Hartung, H.P. (1998) "Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis", Ann. Neurol. 43, 15-24.
33. Mayo, I., Arribas, J., Villoslada, P., Alvarez Do Forno, R., Rodriguez-Vilarino, S., Montalban, X., de Sagarra, M.R. and Castano, J.G. (2002) "The proteasome is a major autoantigen in multiple sclerosis", Brain 125, 2658-2667.
34. Agius, M.A., Kirvan, C.A., Schafer, A.L., Gudipati, E. and Zhu, S. (1999) "High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease", Acta Neurol. Scand. 100, 139-147.
35. Zanetta, J.P., Tranchant, C., Kuchler-Bopp, S., et al. (1994) "Presence of anti-CSL antibodies in the cerebrospinal fluid of patients: a sensitive and specific test in the diagnosis of multiple sclerosis", J. Neuroimmunol. 52, 175-182.
36. Prabhakar, S., Kurien, E., Gupta, R.S., et al. (1994) "Heat shock protein immunoreactivity in the CSF: correlation with oligoclonal banding and demyelinating disease", Neurology 44, 1644-1648.